淀粉糖及其他

Search documents
保龄宝股价跌5.02%,西部利得基金旗下1只基金重仓,持有1.44万股浮亏损失7056元
Xin Lang Cai Jing· 2025-10-21 02:25
10月21日,保龄宝跌5.02%,截至发稿,报9.28元/股,成交7745.48万元,换手率2.23%,总市值35.32亿 元。 截至发稿,张昌平累计任职时间4年352天,现任基金资产总规模15.68亿元,任职期间最佳基金回报 111.93%, 任职期间最差基金回报0.88%。 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 责任编辑:小浪快报 数据显示,西部利得基金旗下1只基金重仓保龄宝。西部利得新富混合A(673120)二季度持有股数1.44 万股,占基金净值比例为4.17%,位居第七大重仓股。根据测算,今日浮亏损失约7056元。 西部利得新富混合A(673120)成立日期2017年6月16日,最新规模181.84万。今年以来亏损5.36%,同 类排名8106/8162;近一年亏损7.13%,同类排名7959/8024;成立以来收益27.84%。 西部利得新富混合A(673120)基金经理为张昌平。 资料显示,保龄宝生物股份有限公司位于山东省德州(禹城)国家高新技术产 ...
保龄宝涨2.20%,成交额3073.88万元,主力资金净流出106.12万元
Xin Lang Cai Jing· 2025-09-24 02:12
Company Overview - Baolingbao Bio-Technology Co., Ltd. is located in Dezhou, Shandong Province, and was established on October 16, 1997. The company was listed on August 28, 2009. Its main business involves the research, production, and sales of functional sugars [1][2]. Financial Performance - For the first half of 2025, Baolingbao achieved operating revenue of 1.399 billion yuan, representing a year-on-year growth of 18.02%. The net profit attributable to shareholders was 92.672 million yuan, reflecting a year-on-year increase of 33.66% [2]. - Since its A-share listing, Baolingbao has distributed a total of 309 million yuan in dividends, with 95.072 million yuan distributed over the past three years [3]. Stock Performance - As of September 24, Baolingbao's stock price increased by 2.20% to 9.77 yuan per share, with a total market capitalization of 3.714 billion yuan. The stock has seen a year-to-date increase of 33.47%, but has declined by 4.96% over the past five trading days, 16.85% over the past 20 days, and 23.73% over the past 60 days [1]. - The stock has appeared on the "Dragon and Tiger List" five times this year, with the most recent occurrence on May 22, where it recorded a net buy of -50.8373 million yuan [1]. Shareholder Information - As of September 10, Baolingbao had 34,400 shareholders, a decrease of 6.59% from the previous period. The average number of circulating shares per shareholder increased by 7.06% to 10,739 shares [2]. Business Segments - The main revenue composition of Baolingbao includes: starch sugars and others (29.89%), sugar-reducing sweeteners (26.55%), feed and by-products (22.40%), probiotics (13.48%), dietary fiber (7.39%), and others (0.29%) [1]. Industry Classification - Baolingbao belongs to the agricultural, forestry, animal husbandry, and fishery sector, specifically under the subcategory of agricultural product processing, and is involved in various concept sectors including sugar substitutes, synthetic biology, biomedicine, small-cap stocks, and participation in the New Third Board [2].